PROFESSOR WARNING FOR PULMONARY HYPERTENSION, WHICH CAUSES HEART FAILURE

Reading time is 2 mins

.
.
HOW DOES PULMONARY HYPERTENSION CAUSE A HEART FAILURE?

Chairman of the Working Group on Pulmonary Vascular and Adult Congenital Heart Diseases of the Turkish Society of Cardiology Prof. Dr. noted that due to the World Day of Pulmonary Hypertension, they organized various events aimed at raising awareness about the disease. Stating that pulmonary hypertension is a serious heart-lung circulatory disorder that can lead to heart failure and death, Prof. Dr. “We are trying to achieve goals such as diagnosing patients as early as possible and providing a chance for a longer and better quality of life with the appropriate treatment strategies,” was said.

Prof. Doctor, pulmonary hypertension is characterized by increased blood pressure in the pulmonary veins, and timely, accurate if left untreated, heart failure, resulting in death, serious heart-lung is a disorder of the circulation, that only was the method of definitive diagnosis and angiographic indicated that specialist centres.

Prof. Doctor, “For the pulmonary hypertension, which can affect people of any age group, is 1.8 times more common in women than in men,” it said.

On May 5, World Pulmonary Hypertension Day, Prof. Dr. stated that a timely and correct treatment strategy should be applied in patients who show symptoms such as shortness of breath, fatigue, chest pain, edema, dizziness, palpitations and hoarseness. Professor Doctor, added that:

“We are trying to diagnose these patients as early as possible and offer them a longer and better quality of life with appropriate treatment strategies by organizing various events to raise awareness about patients with pulmonary hypertension by our working group.

Affect the lives of millions of people in the world that is characterized by an increase in blood pressure pulmonary hypertension in the pulmonary vein, and without distinction of race and ethnicity that can affect people of every age group in a timely manner with accurate if untreated, death may result in serious heart failure and a heart-lung circulation disorder.

US official and non-governmental organizations in the world with all stakeholders of pulmonary hypertension on the day for 05 May 2022 to raise awareness on the World about pulmonary hypertension and organize various activities simultaneously with this relentless disease diagnosis as early as possible, to put quality and appropriate treatment strategies, and we are trying to offer a chance for a life long.”

.
.
.
.

Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.

Awards:

Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.

Certificates:

Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.

Disclaimer:

Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me